Abstract:Abstract Objectives Short chain fatty acids (SCFAs), which are gut microbial fermentation byproducts with suggested positive health effects, have emerged as a therapeutic modality against metabolic diseases like obesity and type 2 diabetes. Alluringly, in vivo SCFA levels are easily modifiable by consumption of fermentable fibers (FF). Most rodent studies on dietary FF supplementation report terminal increased cecal/fecal SCFA levels but the time course of this increase remains elusive. Also, there is limited information on the effect of this sustained SCFA increase on physiology. Thus, we investigated dietary FF-dependent temporal increases in plasma SCFA levels and its metabolic effects on a western diet (WD) mouse model. Methods C57BL/6J male mice (age 10 weeks) were fed test diets for 8 weeks. In Phase I, to establish time-course of plasma SCFA increase, mice were fed the following isocaloric diets: control (low fat + 0% FF); WD; control + 20% FF, where FF was fructooligosaccharides (FOS), inulin (In), guar gum (GG) or pectin (Pec). In Phase II mice were fed a control diet, or a WD with or without 20% FOS, Pec or GG. End points were weekly plasma SCFAs (by MS/MS), body weight, random glucose and insulin, and at the end of experimental period body fat composition and metabolic tests. Results Phase I. Compared to control, WD lowered while FF induced significant increases in total plasma SCFAs (FOS, Pec, GG > In) in a time dependent manner that plateaued beyond 2 weeks. All FF increased propionate and acetate but not butyrate. Phase II. WD caused metabolic dysfunctions (increased body weight and fat mass; glucose intolerance; insulin resistance; P < 0.0001 by two-way ANOVA) that were alleviated in mice fed FF enriched WD (Pec = GG > FOS). Compared to WD, food intake was similar except high in the WD-Pec group, while WD-Pec and GG showed higher energy expenditure. All 3 plasma SCFAs were significantly higher in all WD-FF groups. FF supplementation of the control diet showed no significant difference compared to control. Conclusions We conclude that: 1) FF feeding induced SCFA production reaches saturation within 2 weeks, suggesting selection of specific gut bacterial features; and 2) all FFs were protective from weight gain and its metabolic consequences. Funding Sources 2R01 DK104927 (NIH/NIDDK) Layden.

Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome.

Altered short chain fatty acid profiles induced by dietary fiber intervention regulate AMPK levels and intestinal homeostasis.

Co-activating the AMPK Signaling Axis by Low Molecular Weight Fucoidan LF2 and Fucoxanthin Improves the HFD-induced Metabolic Syndrome in Mice

Beneficial Effects of Flaxseed Polysaccharides on Metabolic Syndrome Via Gut Microbiota in High-Fat Diet Fed Mice

Lipolysis and Thermogenesis in Adipose Tissues As New Potential Mechanisms for Metabolic Benefits of Dietary Fiber.

Macrophage Alpha 1 Amp-Activated Protein Kinase (alpha 1ampk) Antagonizes Fatty Acid-Induced Inflammation Through Sirt1

AMPK Regulation of Glucose, Lipid and Protein Metabolism: Mechanisms and Nutritional Significance.

AMPK, insulin resistance, and the metabolic syndrome

Fiber Diet-Mediated Increases in Short Chain Fatty Acids Alleviate Western Diet Induced Metabolic Dysfunction

Protection against the Metabolic Syndrome by Guar Gum-Derived Short-Chain Fatty Acids Depends on Peroxisome Proliferator-Activated Receptor γ and Glucagon-Like Peptide-1

Effects of Dietary Fiber and Its Components on Metabolic Health

Molecular Mechanisms of Metabolic Syndrome Induced by High Fructose Diet: A Review

Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation

Short-chain fatty acids in control of energy metabolism

Ampk Activation By Metformin Suppresses Abnormal Extracellular Matrix Remodeling In Adipose Tissue And Ameliorates Insulin Resistance In Obesity

Dietary fibers extracted from Saccharina japonica can improve metabolic syndrome and ameliorate gut microbiota dysbiosis induced by high fat diet

1 Propionate Promotes Intestinal Lipolysis and 2 Metabolic Benefits via AMPK / LSD 1 Pathway in Mice 3

Propionate Promotes Intestinal Lipolysis and Metabolic Benefits Via AMPK/LSD1 Pathway in Mice

Dietary Fiber and Metabolic Syndrome: A Meta-Analysis and Review of Related Mechanisms

The Interplay of Dietary Fibers and Intestinal Microbiota Affects Type 2 Diabetes by Generating Short-Chain Fatty Acids

Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.